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ciliary body
Renu Goel1,2†, Krishna R Murthy1,3,4†, Srinivas M Srikanth1,7, Sneha M Pinto1,5, Mitali Bhattacharjee1,3,
Dhanashree S Kelkar1,3, Anil K Madugundu1, Gourav Dey1, Sujatha S Mohan1,2,6, Venkatarangaiah Krishna2,
TS Keshava Prasad1,3,5, Shukti Chakravarti8,9,10, HC Harsha1 and Akhilesh Pandey8,11*Abstract
Background: The ciliary body is the circumferential muscular tissue located just behind the iris in the anterior
chamber of the eye. It plays a pivotal role in the production of aqueous humor, maintenance of the lens zonules
and accommodation by changing the shape of the crystalline lens. The ciliary body is the major target of drugs
against glaucoma as its inhibition leads to a drop in intraocular pressure. A molecular study of the ciliary body
could provide a better understanding about the pathophysiological processes that occur in glaucoma. Thus far, no
large-scale proteomic investigation has been reported for the human ciliary body.
Results: In this study, we have carried out an in-depth LC-MS/MS-based proteomic analysis of normal human ciliary
body and have identified 2,815 proteins. We identified a number of proteins that were previously not described in
the ciliary body including importin 5 (IPO5), atlastin-2 (ATL2), B-cell receptor associated protein 29 (BCAP29), basigin
(BSG), calpain-1 (CAPN1), copine 6 (CPNE6), fibulin 1 (FBLN1) and galectin 1 (LGALS1). We compared the plasma
proteome with the ciliary body proteome and found that the large majority of proteins in the ciliary body were
also detectable in the plasma while 896 proteins were unique to the ciliary body. We also classified proteins using
pathway enrichment analysis and found most of proteins associated with ubiquitin pathway, EIF2 signaling,
glycolysis and gluconeogenesis.
Conclusions: More than 95% of the identified proteins have not been previously described in the ciliary body
proteome. This is the largest catalogue of proteins reported thus far in the ciliary body that should provide new
insights into our understanding of the factors involved in maintaining the secretion of aqueous humor. The
identification of these proteins will aid in understanding various eye diseases of the anterior segment such as
glaucoma and presbyopia.
Keywords: Aqueous humor, Proteome discoverer, Protein biomarkers, Ciliary processes, Non-pigmented epithelial
layer, Pigmented epithelial layer, Cyclitis and glaucomaBackground
The ciliary body, iris and choroid comprise the vascular
uveal coat of the eye. The ciliary body forms a ring along
the inner wall of the globe and extends from the iris
anteriorly to the ora serrata posteriorly as shown in
Figure 1A. It is predominantly made up of smooth* Correspondence: pandey@jhmi.edu
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reproduction in any medium, provided the ormuscle that is arranged in longitudinal radial and circu-
lar fashion. The ciliary body is composed of the ciliary
muscle and ciliary processes. Ciliary processes are ap-
proximately 70 in number in humans and project in-
wards as radial ridges [1]. The ciliary body is highly
vascular and supplied by the anterior ciliary and long
posterior ciliary vessels [2,3]. The ciliary processes con-
sist of a central core of connective tissue stroma which
is covered by a double layered epithelium. The inner
non-pigmented epithelial layer is in direct contact with
the aqueous [4]. It is formed by a layer of columnar
cells which contain numerous mitochondria, rough andd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and





































Figure 1 Schematic structure of the eye and experimental strategy for proteomic analysis of human ciliary body. Panel A. shows
anatomy of the eye with a zoomed in view of the ciliary body. Panel B. depicts the proteomic workflow employed for the study.
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metabolically active cells. The outer-pigmented epithelial
cell layer is a layer of cuboidal cells which are abundant
in melanosomes that are relatively poor in intracellular
organelles. It lies between the non-pigmented epithelial
layer and the connective tissue stroma [1].
The non-pigmented epithelial layer of the ciliary body
secretes aqueous humor by a process of active transport,
through diffusion and ultrafiltration [5]. The aqueous
humor bathes the avascular structures of the eye such as
the crystalline lens, posterior surface of the cornea, the
anterior vitreous and the trabecular meshwork before
exiting the eye through the canal of Schlemm into theepiscleral veins. A small fraction of the aqueous also
exits the eye between the muscle bundles of the ciliary
body to the supraciliary and suprachoroidal spaces, com-
monly called the uveoscleral pathway [5]. This constant
flow of aqueous replenishes the nutrients required for
these avascular tissues and carries away their metabolic
wastes. The aqueous humor dynamics also helps to
maintain the intraocular pressure of the eye that is
essential for maintaining the optical and refractive prop-
erties of the eye [6,7]. The ciliary muscles contract, the
zonules relax and the lens becomes thicker for near
vision while distant vision involves relaxation of the
ciliary muscles, contraction of the zonules and thinning
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ophthalmic pathology such as open and closed angle
glaucoma [8], due to a complex imbalance in aqueous
humor production and drainage, cyclitis or inflammation
of the ciliary body and presbyopia, which is character-
ized by a diminution of the ability of the eye to accom-
modate [9-11].
Identification of the protein constituents of tissues can
lead to a better understanding of their normal physi-
ology. Previous molecular analysis of the ciliary body has
provided some insights into the expression profiles of
the two ciliary epithelia. The majority of proteomic
studies of the human ciliary body reported to date are
based on immunohistochemistry, Western blot or im-
munofluorescence-based studies. Wu et al. identified ni-
tric oxide synthase 1 neuronal (NOS1), NOS2 and
NOS3 by Western blot and immunohistochemistry [12].
Flugel-Koch et al., identified tyrosine hydroxylase, neuro
peptide Y, tachykinin, NOS1, solute carrier family 18
member 3, calbindin 2, calcitonin-related polypeptide
alpha, 2,4-dienoyl CoA reductase 1 mitochondrial by im-
munohistochemical assays [13]. Pattwell et al., identified
enolase 2, opticin (OPTC), S100 calcium binding protein
B, vimentin and collagen type II alpha 1 (COL2A1) by
immunofluorescence assays [14]. Although, proteomic
approaches have been used to identify proteins in eye
tissues such as vitreous, aqueous humor and retina, to
the best of our knowledge, a comprehensive analysis of
proteome of the ciliary body has not yet been carried
out. In this study, we report a comprehensive catalogue
of proteins expressed in the normal ciliary body and pro-
vide the subcellular localization, molecular function and
biological processes associated with these proteins. This
characterization of the ciliary body proteome from
healthy individuals may serve as a valuable template to
compare the ciliary body proteomic changes occurring
in other sight-threatening pathological conditions such
as glaucoma and macular degeneration.
Results and discussion
Proteomic analysis of the ciliary body samples was
carried out by digestion of bands excised from an SDS-
PAGE gel as illustrated in the Figure 1B. MS/MS analysis
was carried out for 30 in-gel digested fractions on an
LTQ-Orbitrap Velos ETD mass spectrometer. The cor-
responding MS data were searched using two different
search algorithms – Mascot and SEQUEST - against the
NCBI RefSeq human protein database 50 (N=33,832
proteins) with known contaminants. MS/MS spectra
resulted in identification of 157,782 peptide-spectral
matches (PSM) and these PSM were filtered for first
rank assignment that passed 1% FDR threshold. In total
19,547 unique peptides sequences were identified and
these peptides resulted in identification of 2,815 pro-teins. A complete list of proteins identified in the ciliary
body is provided in Additional file 1: Table S1 along with
unique number of peptides, spectrum count, sequence
coverage, intensity based absolute quantification (iBAQ)
score, subcellular localization, molecular function, bio-
logical process and domains/motifs. A non-redundant
list of peptides identified from this study is provided in
Additional file 2: Table S2.
Proteins previously described in the ciliary body
Among the identified proteins, we found a number of
proteins that had been previously described in the ciliary
body, confirming the validity of our proteomic approach.
A search of the published literature resulted in <50 pro-
teins that have been reported in the human ciliary body
to date. Many groups using different techniques as sum-
marized in Table 1 identified these as individual proteins
based on targeted molecules of interest. Among the
proteins previously shown to be in the ciliary body are
collagen type XVIII alpha 1 (COL18A1), cytochrome
P450 family 1 subfamily B polypeptide 1 (CYP1B1),
Opticin (OPTC) and aquaporin 1 (AQP1). Representative
MS/MS spectra of these identified proteins in this study
are shown in Figure 2.
Opticin is associated with the extracellular matrix and
belongs to leucine-rich repeat protein family [15]. It is
also abundantly expressed in other parts of the eye in-
cluding the vitreous humor, cornea, iris and retina
[15-18]. OPTC has been reported as a candidate gene for
primary open angle glaucoma [19]. Collagen alpha-1
(XVIII) (COL18A1) is expressed in both pigmented and
non-pigmented epithelial layer cells and confirmed by
immunohistochemistry [17,20,21]. It is an extracellular
matrix protein with collagen and thrombospondin like
domains and releases endostatin multiple biological ac-
tivities. Endostatin is a proteolytic fragment of collagen
XVIII, released from its C-terminal end, and inhibits
endothelial cell proliferation, tumorigenesis and angio-
genesis [22].
CYP1B1 is a member of the cytochrome P450 super-
family of enzymes. Doshi et al. have shown expression
of CYP1B1 in non-pigmented epithelial layer by immu-
noreactivity screening [23]. CYP1B1 is expressed in fetal
eyes and plays a vital role in morphogenesis of iris and
ciliary body [24]. Aquaporins are integral membrane
proteins that function as molecular water channel pro-
teins. These proteins have pores through which water
crosses the plasma membranes of various human tissues.
In the eye, water homeostasis is essential for protecting
the epithelium, and maintaining ocular transparency for
optimal vision [25]. The sodium/potassium transporting
ATPase subunit activates Na+ and K+ located in the
ciliary body to recruit energy required for transport
by hydrolysis of adenosine triphosphate to adenosine
Table 1 A summary of published studies for the ciliary body protein identification
Study Method Source Proteins identified
1 Wu et al. [12] Immunohistochemistry, Western blot PCE and NPCE cells NOS1
2 Wu et al. [12] Immunohistochemistry, Western blot PCE and NPCE cells NOS2
3 Wu et al. [12] Immunohistochemistry, Western blot PCE and NPCE cells NOS3
4 Krueger et al. [59] Immunohistochemistry PCE and NPCE cells SCNN1B
5 Krueger et al. [59] Immunohistochemistry PCE and NPCE cells SCNN1G
6 Gabriel et al. [60] Immunohistochemistry, Western blot Ciliary body ADAMTSL4
7 Yamanouchi et al. [61] Immunofluorescence, immunohistochemical assay NPCE FBN1
8 Yamanouchi et al. [61] Immunofluorescence, immunohistochemical assay NPCE FBN2
9 Chowdhury et al. [62] Immunohistochemistry, Western blot Ciliary body SPP1
10 Russell-Randall et al. [63] Immunofluorescence NPCE OPRK1
11 Zhang et al. [64] immunofluorescence NPCE BEST2
12 Kraft et al. [65] Immunofluorescence PCE and NPCE cells SLCO2A1
13 Kraft et al. [65] Immunofluorescence PCE and NPCE cells SLCO2B1
14 Wang et al. [66] Immunohistochemistry NPCE COX2
15 Flugel-Koch et al. [13] Immunohistochemical Ciliary body TH
16 Flugel-Koch et al. [13] Immunohistochemical Ciliary body NPY
17 Flugel-Koch et al. [13] Immunohistochemical Ciliary body TAC1
18 Flugel-Koch et al. [13] Immunohistochemical Ciliary body SLC18A3
19 Flugel-Koch et al. [13] Immunohistochemical Ciliary body NOS1
20 Flugel-Koch et al. [13] Immunohistochemical Ciliary body CALB2
21 Flugel-Koch et al. [13] Immunohistochemical Ciliary body CALCA
22 Flugel-Koch et al. [13] Immunohistochemical Ciliary body DECR1
23 Yucel et al. [67] Immunofluorescence Ciliary body PDPN
24 Yucel et al. [67] Immunofluorescence Ciliary body LYVE1
28 Mao et al. [68] Immunohistochemical NPCE cells SH3PXD2B
29 Ooi et al. [69] Western blot, Immunofluorescence Ciliary body ADRA2A
30 Webb et al. [70] Immunofluorescence and immunoblot NPCE KLK1
31 Webb et al. [70] Western blot Ciliary body BDKRB1
32 Webb et al. [70] Western blot Ciliary body BDKRB2
33 Pattwell et al. [14] Immunofluorescence NPCE Opticin
34 Pattwell et al. [14] Immunofluorescence NPCE COL2A1
35 Pecorella et al. [71] Immunohistochemistry Ciliary body ENO2
36 Pecorella et al. [71] Immunohistochemistry Ciliary body S100B
37 Pecorella et al. [71] Immunohistochemistry Ciliary body VIM
38 Marmorstein et al. [72] Immunofluorescence NPCE BEST2
39 Ostojic et al. [73] Immunofluorescence NPCE CYGB
40 Ostojic et al. [73] Immunofluorescence NPCE NGB
41 Assheton et al. [74] Immunofluorescence NPCE Opticin
42 Toyran et al. [75] Immunohistochemistry NPCE BMP7
43 Toyran et al. [75] Immunohistochemistry NPCE GDF5
44 Maatta et al. [20] Immunohistochemistry PCE and NPCE cells COL18A1
45 Ohlmann et al. [21] Immunohistochemistry NPCE COL18A1
46 Ramesh et al. [17] Immunolocalisation Ciliary body Opticin
47 Ramesh et al. [17] Immunolocalisation Ciliary body COL18A1
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Table 1 A summary of published studies for the ciliary body protein identification (Continued)
48 Bishop et al. [76] in situ hybridisation NPCE Opticin
49 Wollensak et al. [77] Immunohistochemistry Ciliary body ECE1
50 Doshi et al. [23] Immunoreactivity NPCE CYP1B1
51 Sonsino et al. [78] Immunofluorescence NPCE TJP1
52 Sonsino et al. [78] Immunofluorescence NPCE OCLN
53 Hamann et al. [79] Immunohistochemistry Ciliary body AQP1
54 Wang et al. [80] Immunoreactivity Ciliary body LAMB1
55 Wang et al. [80] Immunoreactivity Ciliary body LAMB2
56 Kumagai et al. [81] Immunohistochemistry NPCE SLC2A1
57 Peress et al. [82] Immunohistochemical PCE and NPCE cells TGFB2
58 Peress et al. [82] Immunohistochemical PCE and NPCE cells TGFB3
59 Wistrand et al. [83] Immunofluorescence PCE and NPCE cells CA2
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the production of aqueous humor in the ciliary body
epithelia and movement of aqueous humor into the an-
terior chamber of the eye [27].
Novel proteins identified in the ciliary body
The majority of identified proteins were not previously
reported in the ciliary body proteome. A partial list of
these proteins is provided in Table 2. Representative
MS/MS spectra of four proteins identified in this study -
desmin, 26S proteasome non-ATPase regulatory subunit
6, exportin 1 and vacuolar protein sorting-associated
protein 35 are shown in Figure 3 and described in the
subsequent sections.
Vesicle mediated protein sorting (VPS) family plays a
significant role in separation of intracellular molecules
into different organelles. VPS1 to VPS40 proteins are in-

























































































Figure 2 MS/MS spectra of previously described proteins. A. The peptide
TEAPSATGQASSLLGGR from collagen, type XVIII, alpha 1 C. The Peptide QVLEGH
peptide from aquaporin 1.and retrograde transport of molecules from endosomes
to the trans-golgi network. The heteropentameric ret-
romer system consists of dimers of SNX1, SNX2,
SNX5, SNX6, and a heterotrimer of vacuolar protein
sorting-associated protein 26 (VPS26), VPS29, VPS35
[28]. Sorting nexin dimer is essential for the employment
of retromer to the endosomal membrane, and VPS pro-
teins assist in the cargo recognition. Interestingly, we
found most of the molecules listed in intracellular traf-
ficking and protein sorting mechanisms in our study
given in Additional file 1: Table S1.
Desmin is a muscle specific class III intermediate fila-
ment which connects myofibrils to the plasma mem-
brane. Mutations in the Desmin gene are associated with
desmin related myopathy which affects cardiac, skeletal,
and smooth muscle [29]. It should be further studied to
see the role in the ciliary body. Karyopherin family pro-

























































































IDLSNNLISSIDNDAFR from opticin B. shows the MS/MS spectra of peptide
VLSEAR belongs to cytochrome p450 1B1 D. VWTSGQVEEYDLDADDINSR





Biological process Molecular function
P4HB Calpain small subunit 1 Endoplasmic reticulum Protein metabolism Isomerase activity
GLG1 Golgi apparatus protein 1 Golgi apparatus Biological_process unknown Receptor binding
CD47 Leukocyte surface antigen CD47 Cell surface, Plasma
membrane
Immune response Molecular function
unknown
KDELR2 ER lumen protein retaining receptor 2 Endoplasmic reticulum Transport Transporter activity
NCF2 Neutrophil cytosol factor 2 Cytoplasm Metabolism, Energy pathways Catalytic activity
PFN1 Profilin-1 Cytoplasm Cell growth Cytoskeletal protein
binding
MDH2 Myosin-11 Mitochondrion Metabolism, Energy pathways Catalytic activity
CBR1 Pyruvate kinase isozymes M1/M2 Cytoplasm Metabolism, Energy pathways Oxidoreductase activity
APOA1 Tubulin beta-2A chain Extracellular Transport Transporter activity
HSPA5 78 kDa glucose-regulated protein Endoplasmic reticulum Protein metabolism Chaperone activity
EEF1A1 Elongation factor 1-alpha 1 Cytoplasm Regulation of cell cycle Transcription regulator
activity
DDAH1 Alpha-1-antitrypsin Cytoplasm Metabolism, Energy pathways Hydrolase activity
C3 Complement C3 Extracellular Immune response Complement activity
RAB1A NADH-ubiquinone oxidoreductase 75 kDa subunit,
mitochondrial
Golgi apparatus Cell communication, Signal
transduction
GTPase activity
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the nuclear pore. It mediates nuclear import and export
of ribosomal proteins required for ribosome biogenesis.
Molecules transport occurs across the nuclear envelope
through importins and exportins proteins. Both proteins
are regulated by the small GTPase Ran and localized to
nucleus, cytoplasm, nucleolus, kinetochore and cytosol
[30-32]. Importins identify their substrates in the cyto-
plasm and transport them to the nucleus. Here, the


















































































Figure 3 MS/MS spectra of novel proteins identified. A. shows the MS/MS
GAEILEVLHSLPAVR, derived from 26S proteasome non-ATPase regulatory subun
Peptide from vacuolar sorting-associated protein 35.Exportins interact with their substrates in the presence
of RanGTP in the nucleus and release the cargo in the
cytoplasm after GTP hydrolysis [33]. We found exportin
1 (XPO1) which interacts with EIF5A [34], NUP214
[35], NXF3 [36], ORC1 [37], Ran binding protein 2 [38],
DDX3 [39], Survivin [40], and telomere reverse tran-
scriptase [41]. XPO1 shuttles between the nucleus and
cytoplasm. It is overexpressed in cancer which results in
alternate localization of multiple tumor suppressor pro-



















































































spectra of peptide, EEAENNLAAFR, from Desmin B. The peptide,
it 6 C. NVDILKDPETVK Peptide from exportin-1 D. SEDPDQQYLILNTAR
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humor and plasma proteomes
The fenestrated ciliary body capillary endothelia allow
the flow of blood plasma across the ciliary stroma which
helps in the secretion of aqueous humor by the ciliary
epithelium. We were interested in proteins derived from
ciliary body, which are directly relevant to its physiology,
and not those derived from the blood diffusing into the
ciliary body. There is a blood aqueous barrier, which per-
mits solutes from the blood vessels of the ciliary stroma
into the aqueous humor [11]. We compared the ciliary
body proteome with human plasma proteome from
Plasma Proteome Database [43] and aqueous humor
proteome in order to get the ciliary body specific pro-
teins. A total of 9,393 plasma proteins were compared
with the ciliary body proteome and we observed that
896 proteins were unique to the ciliary body proteome
as seen in Figure 4A. Proteins detected in the ciliary
body were also compared to proteins previously reported
in the aqueous humor [7,44-47]. We found 211 proteins
that were also reported in the aqueous humor proteome
Figure 4B. Only seven of these 211 proteins were de-
scribed in the plasma (Figure 4C). These unique proteins
are CRYGD crystallin, gamma D (CRYGD), crystallin,
gamma S (CRYGS) and crystallin, gamma C (CRYGC),
which maintain the transparency and refractive index of
the lens [48,49]. Gamma crystallins have been involved
in cataract formation due to aging or mutations. The
source of these proteins is likely to be the aqueous
humor and not the plasma, as the lens, where these are




 Common proteins in Ciliary body and Plasma
C
Figure 4 Comparison of the ciliary body proteome with the aqueous
ciliary body proteins with plasma proteins annotated in the Plasma Proteom
proteome with aqueous humor proteome annotated from the published li
the ciliary body and plasma with those that are common to the ciliary bodnutrient supply from the aqueous humor. In addition
the aqueous humor removes metabolic waste from the
lens. Another molecule is pyruvate kinase muscle (PKM),
which is involved in glycolysis and serves as a key regula-
tor of energy metabolism in proliferating cells. Frizzled-
related protein (FRZB) is secreted protein and plays a
significant role in the loss of the Wnt signaling pathway
in different type of cancers by down regulation of this
gene [50]. Ubiquitin fusion degradation 1 (UFD1L) forms
complex with nuclear protein localization 4 (NPLOC4)
and valosin containing protein (VCP). NPLOC4 and
VCP are also identified in this study. This complex is re-
quired for the degradation of ubiquitinated proteins [51].
Retinoschisin 1 (RS1) plays a significant role in the cellu-
lar organization of the retina [44,45].
Data availability
The raw data derived from the ciliary body proteome is
available from several public data repositories. The peptide
identifications and MS/MS spectra are available on
through Human Proteinpedia (http://www.humanprotein
pedia.org) as accession number HuPA_ 00708. The raw
data described in this study is freely available from
ProteomeCommons.org. Online versions of the data may
be found at https://proteomecommons.org/dataset.jsp?
i=78277. The data from this study may also be down-
loaded from Tranche (https://www.proteomecommons.
org/tranche/) using the following hash UqPG6uWQU4
qG5oAJ9fPxBHNjbvNoBPhyXvoj6T2p4p8VY4S8cNnpeK-
bpaeROT5diReS2/Wzvbf0e8rGQxWj/yv6jSYUAAAAAA
AAClQ== and https://proteomecommons.org/dataset.jsp?2580 211 321
Ciliary body Aqueous humor
B
7
 Common proteins in Ciliary body and Aqueous humor
humor and plasma proteome. Panel A shows comparison of the
e Database. Panel B depicts comparison of the ciliary body
terature. Panel C shows a comparison of proteins that are common to
y and the aqueous humor.





The identified ciliary body proteins were functionally
categorized based on subcellular localization, molecular
function and biological processes by searching against
the manually-curated Human Protein Reference Data-
base (HPRD; http://www.hprd.org) [52]. The analysis
returned only those classifications with at least 2% differ-
ence between the annotation terms to limit the number
of classifications types. As illustrated in Figure 5A, the
majority of the proteins reported in our study were lo-
calized to the cytoplasm (27%), nucleus (15%), plasma
membrane (10%) or the mitochondria (10%) while 16%
of these were unclassified. In the molecular function cat-
egory, GO terms related to transporter activity are over-
represented. This was expected as the ciliary body
secretes aqueous humor by a process of active transport.
The majority of the proteins are involved in catalytic ac-
tivity, GTPase activity, hydrolase activity and structural
molecule activity as seen in Figure 5B. A large group of
proteins are still unclassified in terms of their molecular
function. Moreover, in terms of biological processes, the
ciliary body enriched proteins were comprised of a sub-






































Figure 5 Subcellular localization and functional annotation of protein
subcellular localization of identified proteins B. Molecular function of ident
regarding proteins was obtained from Human Protein Reference Databaseenergy pathway (13%) related proteins owing to presence
of numerous mitochondria in the inner non-pigmented
epithelial layer.
Biological network analysis
Ingenuity Pathway Analysis was used to facilitate the
identification of biological canonical signaling and meta-
bolic pathways. Table 3 depicts the ten most significant
pathways enriched by IPA in the ciliary body proteome.
In the ubiquitin pathway, one such significant pathway
in our results, proteins are tagged for degradation
through ubiquitin. The resulting polyubiquitin chain is
bound by the proteasome leading to degradation of the
tagged protein. The 26S proteasomes are protein com-
plexes of 2 complexes, a 20S core and a 19S regulator
that degrade unneeded or damaged proteins by proteoly-
sis. The 20S core is composed of 28 non-identical sub-
units, 7 alpha subunits, 7 beta subunits and the 19S
regulator is composed of 6 ATPase subunits and 12
non-ATPase subunits. This proteasome recognizes pol-
yubiquitin tags attached to protein substrates and initi-
ates the degradation process. In the ubiquitination
cascade, E1 can bind with E2s which further bind E3s in
a hierarchical way [53] as shown in Additional file 3:
Figure S1. In our study, we identified many E1 ubi
quitin-like modifier-activating enzymes including UBA1































s identified from the ciliary body. A. Gene Ontology analysis for
ified proteins C. Biological processes of the identified proteins. The data
(www.hprd.org).
Table 3 Details of Ingenuity Pathways Analysis (IPA) of
top ten canonical pathways
Enriched pathways P-value Ratio
Ubiquitination pathway 2.01E-14 94/263
tRNA charging 2.63E-14 28/38
EIF2 signaling 3.36E-12 68/182
Glycolysis I 1.2E-11 19/23
Gluconeogenesis 4.84E-11 19/24
Valine degradation 5.96E-11 16/18
Ethanol degradation 2.32 E-10 21/30
Caveolar mediated endocytosis signaling 7.56 E-10 35/81
Integrin signaling 1.23 E-09 68/205
TCA cycle 3.32 E-09 17/23
Table 4 Clinical details of donors used in this study
Sample ID Age (years) Sex Ethnicity
CB01 80 Female Indian
CB02 94 Female Indian
CB03 89 Male Indian
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(UBE3A), which helps ubiquitin to attach to a target
protein. We also identified deubiquitinating enzymes
such as ubiquitin carboxyl-terminal hydrolase 5 (USP5),
USP7, USP11, USP14, USP15 which are key regulators
of ubiquitin mediated pathways [54]. In the proteosomal
family, we reported many proteasomal proteins as listed
in Additional file 1: Table S1.
Conclusions
The ciliary body is a specialized tissue, which has a
major role in the formation of the blood-aqueous bar-
rier. It performs many functions such as maintaining a
transparent medium inside the eye, nourishing the avas-
cular ocular tissues and maintaining the size and shape
of the eye by regulating the intra ocular pressure. By
virtue of the unique functions performed by the ciliary
body, it is of interest to understand the proteomics pro-
file of this tissue. Our study provides a high resolution
mass spectrometric proteome analysis of the ciliary body
perhaps identifying the largest set of proteins that appear
to be specific to the ciliary body. The information from
our study is likely to serve as a baseline for future stud-
ies aimed at studying ophthalmic disorders such as glau-
coma, uveitis and presbyopia.
Methods
Sample collection
The ciliary body samples for the proteomic analysis were
obtained at autopsy after obtaining approval from the in-
stitutional ethics committee. Clinical details of the do-
nors are documented in Table 4. There was no medical
history of glaucoma, other eye diseases or malignancy.
The three eye globes were enucleated 3–4 hours post
mortem and kept frozen. No eye abnormality was ob-
served by light microscopy. After removal of the cornea,
ciliary bodies were excised and stored at −80°C. The cil-
iary body samples were lysed in 0.5% sodium dodecylsulfate (SDS), sonicated, homogenized and centrifuged at
13,000 rpm for 15 minutes at 4°C. The supernatant was
collected and protein quantitation was carried out by
Lowry’s assay (Bio-Rad Hercules, CA; USA). We recovered
2.1, 1.8 and 1.5 mg of proteins from three donor samples.
In-gel digestion
The pooled ciliary body samples (~300 μg of protein)
were resolved by SDS-PAGE and stained using colloidal
Coommassie blue stain. The lane was excised into pieces
and destained with 50% acetonitrile in 40 mM ammo-
nium bicarbonate followed by dehydration of the gel
pieces with 100% acetonitrile. In-gel reduction was car-
ried out using 5 mM dithiothreitol (60°C for 45 minutes)
followed by alkylation using 20 mM iodoacetamide
(room temperature for 10 min). These steps reduce the
disulfide bonds in proteins and alkylates the free SH
groups of Cys residues to yield carbamidomethyl Cys re-
spectively. Removed iodoacetamide and dehydrated the
gel pieces by acetonitrile. In-gel digestion was carried
out by sequencing grade modified porcine trypsin at a
concentration of 10 ng/μl (Promega, Madison, WI, US)
in chilled 50 mM ammonium bicarbonate at 4°C to
minimize autocatalysis by trypsin and incubated for 45
minutes on ice [55]. Excess trypsin was removed and the
gel pieces were immersed in ammonium bicarbonate
and incubated overnight at 37°C. The peptides were
extracted from the gel bands using 0.4% formic acid in
3% acetonitrile twice, once using 0.4% formic acid in
50% acetonitrile and once using 100% acetonitrile. The
extracted peptides were dried using speedvac and stored
at −80°C until LC-MS/MS analysis.
LC-MS/MS analysis
LC-MS/MS analyses of the samples was carried out on a
high resolution Fourier transform mass spectrometer,
LTQ-Orbitrap Velos (Thermo, Bremen, Germany), as
previously described [56,57]. The mass spectrometer was
interfaced with Agilent’s 1200 nano-LC system to a trap
column (2 cm × 75 μm, C18 material 5 μm, 120 Å) and
an analytical column (10 cm × 75 μm, C18 material
5 μm, 120 Å). Electrospray source was fitted with an 8
μm emitter tip (New Objective, Woburn, MA) and was
applied a voltage of 2000 V. Peptide samples were loaded
onto trap column in 3% solvent B (90% acetonitrile in
0.1% formic acid) and washed for 5 minutes. Peptides
were eluted using a gradient of 3-35% solvent B for 60
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2.1 (Thermo Electron, Bremen, Germany) was used for
data acquisition. MS spectra were acquired in a data-
dependent manner targeting the twenty most abundant
ions in each survey scan in the range of m/z 350 to
1,800. The selected ions were excluded for 30s after two
MS/MS scans. Target ion quantity for FT full MS and
MS2 were 5 × 105 and 2 × 105, respectively. The precur-
sor ion fragmentation was carried out using higher-
energy collision dissociation (HCD) using 40% normal-
ized collision energy. The mass spectrometry analysis
was carried out with survey scans (MS) acquired at a
resolution of 60,000 at 400 m/z and fragment ion scan
(MS/MS) acquired at a resolution of 15,000 at 400 m/z.
Data analysis
The mass spectrometry data analysis was processed
using the Proteome Discoverer software (Version 1.3,
Thermo Scientific, Bremen, Germany). Mascot and
SEQUEST search engines were employed for database
searching. The mass spectrometry data was searched
against NCBI RefSeq 50 human protein database con-
taining 34,346 sequences with known contaminants.
Scans were filtered for - signal to noise ratio of 1.5 and
precursor mass range of 300–5000 Da for generation of
peak lists. Carbamidomethylation of cysteine was used
as the fixed modification and oxidation of methionine as
variable modifications. Peptide mass tolerance and frag-
ment mass tolerance were set as 20 ppm and 0.1 Da. We
used 1% FDR score cut-off to export the peptide data
used for the analysis. GO analysis was carried out using
Human Protein Reference Database (HPRD: http://www.
hprd.org) [52] and Human Proteinpedia [58] which are
GO compliant databases. Pathway analyses were carried
out using Ingenuity Pathways Analysis (IPA) software ver-
sion 7.1 available at http://www.ingenuity.com (Ingenuity
Systems, Mountain View, CA, USA). Pathway networks
were enriched by IPA with corresponding scores.
Additional files
Additional file 1: Table S1. A complete list of proteins identified in the
ciliary body. This table illustrates reported proteins gene accession, gene
symbol, RefSeq accession, protein name, intensity based absolute
quantification (iBAQ) score, unique no of peptides, sequence coverage,
subcellular localization, molecular function, biological process and
domains/motifs.
Additional file 2: Table S2. A list of all peptides identified in the ciliary
body. This table list the identified peptides in the ciliary body along with
protein accession, gene symbol, protein name, Xcorr, Ion score, SEQUEST
modifications, Mascot identifications, m/z and delta mass.
Additional file 3: Figure S1. Ingenuity Pathway Analysis (IPA) based
enrichment of molecular pathway networks. The most significant
pathway enriched by IPA in the ciliary body proteome is the ubiquitin
pathway. In this cascade, E1 binds with E2s which further bind E3s in a
hierarchical way. It results in polyubiquitin chain which leads todegradation of the tagged protein. Proteosomal family also degrade
damaged proteins by proteolysis. We reported proteasome subunit alpha
type 1 and beta type 1. Ubiquitination and proteasomal degradation is
essential for cell cycle, transcription and responses to immune and
inflammation.
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